Investigators hypothesized that spike protein antibody titers would be associated with disease severity and symptoms, and that both spike protein antibody titers and ACE2 neutralization would increase after mRNA BNT162b2 COVID-19 vaccination. Here, ACE2 is linked to COVID-19.